BIO Buzz 2018 Day 1

BIO IS OUR BUSINESS Over the years the biggest names in the business have taken notice of homegrown Oklahoma biotech companies. With a burgeoning innovation district of our own and total annual revenues exceeding $6.7 billion, our best days are ahead. $665 million Selexys Pharmaceuticals Novartis

$270 million

Crescendo Bioscience

Myriad Supply

Stop by pavilion #2621 to learn more about how your company or organization can benefit from Oklahoma’s power of partnership.

$206 million

Novazyme Pharmaceuticals

Genzyme

2 BIO BUZZ | JUNE 5, 2018 | ISSUE ONE | BOSTON, MA BE THE FIRST TO HEAR ABOUT OKLAHOMA’S NEXT SUCCESSES Oklahoma Bioscience Association | okbio.org | Pavilion #2621

Made with FlippingBook Online newsletter